iRhythm Holdings to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
iRhythm Holdings (NASDAQ: IRTC) will release fourth quarter and full year 2025 financial results after market close on February 19, 2026.
Rhea-AI Summary
iRhythm Holdings (NASDAQ: IRTC) will release fourth quarter and full year 2025 financial results after market close on February 19, 2026. Management will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET with a live and archived webcast available on the company’s investor site.
Details
News Market Reaction – IRTC
On Feb 6, the first trading day after this news, IRTC closed 0.19% below the previous close.
Data tracked by StockTitan Argus for the Feb 6 session.
Key Figures
- Earnings release date
- February 19, 2026
- Q4 and full-year 2025 financial results release after market close
- Conference call time PT
- 1:30 p.m. PT
- Start time for Q4 and full-year 2025 results call
- Conference call time ET
- 4:30 p.m. ET
- Start time for Q4 and full-year 2025 results call
Historical Context
-
Preliminary Q4 2025 revenue beat guidance and raised 2026 outlook.
-
Announcement of J.P. Morgan Healthcare Conference presentation schedule.
-
Large APHRS 2025 analysis supporting Zio LTCM performance across populations.
-
Publication and AHA data highlighting benefits of longer-term Zio monitoring.
-
Participation in multiple upcoming investor conferences with webcast access.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN FRANCISCO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the fourth quarter and full year 2025 after the close of trading on Thursday, February 19, 2026. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.
Interested parties may access a live and archived webcast of the conference call on the “Quarterly Results” section of the company’s investor website at investors.irhythmtech.com.
About iRhythm Holdings, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.
Investor Contact
Stephanie Zhadkevich
investors@irhythmtech.com
Media Contact
Kassandra Perry
mediarelations@irhythmtech.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.